Infection in TKA - Diagnosis and Treatment Strategies
Nicolaas C. Budhiparama, MD, PhD (LUMC, NL), PhD (UGM, ID), FICS, Prof., INDONESIA Cécile Batailler, MD, PhD, FRANCE Michael Matthew Decker, MD, MSc, UNITED STATES Nanne P. Kort, MD, PhD, NETHERLANDS Umile Giuseppe Longo, MD, MSc, PhD, Prof., ITALY Sam Oussedik, FRCS, UNITED KINGDOM Vitor Barion Castro De Padua, PhD, BRAZIL Simon W. Young, MD, FRACS, NEW ZEALAND
2025 Congress
Instructional Course Lecture
2025
Not yet rated
General Objectives:
To enhance participants’ knowledge and application of the latest updates, trends, and future directions in the prevention, diagnosis, and treatment of prosthetic knee joint infections.
Specific Objectives:
By the end of this symposium, participants will be able to:
- Analyze global trends in periprosthetic joint infections (PJIs), including the rising incidence of multidrug-resistant (MDR) infections.
- Understand the challenges of diagnosing polymicrobial infections and explore recent advancements in diagnostic technologies, including biomarkers, molecular-based, and culture-based methods.
- Explain the role of prophylactic antibiotics in preventing PJIs, including optimal timing, selection, and dosing based on patient characteristics and surgical factors.
- Gain insights into the role of artificial intelligence (AI) in PJI management, particularly in predicting the success rates of procedures like DAIR (Debridement, Antibiotics, and Implant Retention).
- Outline evidence-based treatment strategies for managing infected TKA, from classic approaches to novel treatment modalities, and determine the appropriate strategy for each case.